BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 14643418)

  • 1. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal.
    Huang X
    Mutat Res; 2003 Dec; 533(1-2):153-71. PubMed ID: 14643418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of iron in neoplasms].
    Poljak-Blazi M
    Lijec Vjesn; 2000; 122(9-10):234-8. PubMed ID: 11210820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis.
    Kabat GC; Rohan TE
    Cancer Causes Control; 2007 Dec; 18(10):1047-53. PubMed ID: 17823849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron and hepatocellular carcinoma.
    Deugnier Y; Turlin B
    J Gastroenterol Hepatol; 2001 May; 16(5):491-4. PubMed ID: 11350542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological autoxidation. I. Decontrolled iron: an ultimate carcinogen and toxicant: an hypothesis.
    Kon SH
    Med Hypotheses; 1978; 4(5):445-71. PubMed ID: 38381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin and Turmeric Modulate the Tumor-Promoting Effects of Iron In Vitro.
    Messner DJ; Robinson T; Kowdley KV
    Nutr Cancer; 2017 Apr; 69(3):481-489. PubMed ID: 28129008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron promotes DEN initiated GST-P foci in rat liver.
    Carthew P; Nolan BM; Smith AG; Edwards RE
    Carcinogenesis; 1997 Mar; 18(3):599-603. PubMed ID: 9067562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that iron-overload promotes 7,12-dimethylbenz(a)anthracene- induced skin tumorigenesis in mice.
    Rezazadeh H; Athar M
    Redox Rep; 1997; 3(5-6):303-9. PubMed ID: 9754329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour promotion versus tumour suppression in chronic hepatic iron overload.
    Bloomer SA; Brown KE
    Cell Biochem Funct; 2015 Jun; 33(4):241-8. PubMed ID: 26059599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium.
    Chervona Y; Arita A; Costa M
    Metallomics; 2012 Jul; 4(7):619-27. PubMed ID: 22473328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nitric oxide in iron-induced rat renal injury.
    Kadkhodaee M; Gol A
    Hum Exp Toxicol; 2004 Nov; 23(11):533-6. PubMed ID: 15625779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload augments 7,12-dimethylbenz(a)anthracene-initiated and 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumorigenesis.
    Rezazadeh H; Julka PK; Athar M
    Skin Pharmacol Appl Skin Physiol; 1998; 11(2):98-103. PubMed ID: 9603660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor promotion by copper-overloading and its enhancement by excess iron accumulation involving oxidative stress responses in the early stage of a rat two-stage hepatocarcinogenesis model.
    Mizukami S; Ichimura R; Kemmochi S; Wang L; Taniai E; Mitsumori K; Shibutani M
    Chem Biol Interact; 2010 May; 185(3):189-201. PubMed ID: 20302851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling by carcinogenic metals and metal-induced reactive oxygen species.
    Harris GK; Shi X
    Mutat Res; 2003 Dec; 533(1-2):183-200. PubMed ID: 14643420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-induced carcinogenesis: the role of redox regulation.
    Toyokuni S
    Free Radic Biol Med; 1996; 20(4):553-66. PubMed ID: 8904296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?
    Wijarnpreecha K; Kumfu S; Chattipakorn SC; Chattipakorn N
    Hemoglobin; 2015; 39(1):9-17. PubMed ID: 25572185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Iron overload and cancer].
    Blanc JF; Bioulac-Sage P; Balabaud C
    Bull Acad Natl Med; 2000; 184(2):355-63. PubMed ID: 10989544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.
    Preziosi ME; Singh S; Valore EV; Jung G; Popovic B; Poddar M; Nagarajan S; Ganz T; Monga SP
    J Hepatol; 2017 Aug; 67(2):360-369. PubMed ID: 28341391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron hypothesis of cardiovascular disease: still controversial.
    Aursulesei V; Cozma A; Krasniqi A
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):901-9. PubMed ID: 25581946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of iron in diabetes and its complications.
    Swaminathan S; Fonseca VA; Alam MG; Shah SV
    Diabetes Care; 2007 Jul; 30(7):1926-33. PubMed ID: 17429063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.